Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Resources
Guide or handbook | 2022
Drug checking, Digital health, Clinical guidance
Guidelines | 2019
Clinical guidance, About prescribers, Injecting drugs, Safer supply
Guide or handbook | 2020
Clinical guidance, Illegal drugs, About prescribers
Lit review | 2012
Stimulants, About prescribers, Clinical guidance
The objectives of this study are to (1) identify changes introduced to OAT clinical guidelines in Ireland during the pandemic; and (2) develop consensus on whether the new recommendations should be
Original research | 2022
Policy/Regulatory, Clinical guidance
Guide or handbook | 2022
Safer supply, Harm reduction, Clinical guidance, Policy/Regulatory, About prescribers
Discontinuation from benzodiazepines can be problematic for patients and may result in a withdrawal syndrome, which can be protracted and last months to years.
Original research | 2022
Clinical guidance, Overdose, Outcomes
BZDs are often a difficult drug class to cease once neuroadaptation has occurred; recommendations usually involve gradual dose reductions of variable rates.
Original research | 2022
Withdrawal, Clinical guidance
Guidelines | 2022
Clinical guidance, About prescribers, Injecting drugs
Guidelines | 2020
Clinical guidance, Advocacy, Barriers and enablers, Hospitals, About prescribers
Guide or handbook | 2022
Safer supply, Clinical guidance, About prescribers
Case study | 2022
Clinical guidance, Hospitals, About prescribers, Barriers and enablers, Outcomes
Guidelines | 2021
Withdrawal, Clinical guidance, About prescribers
Guidelines | 2018
SCS/OPS, Clinical guidance, Harm reduction, Social services, Illegal drugs
Formulaire de sélection/d’évaluation | 2022
à propos des personnes qui utilisent des drogues, à propos des prescripteurs, les guides de pratique clinique, le sevrage, l'équité
The Clinical Opiate Withdrawal Scale (COWS) is a validated, clinician-administered instrument initially developed and validated for English-speaking populations.
Original research | 2022
Clinical guidance, Equity, Withdrawal, About prescribers
Guide or handbook | 2022
Substitution/OAT, Clinical guidance, Policy/Regulatory, Wrap-around services, About prescribers, Hesitancy of prescribers , Transitions in care/treatment
The “Six Moments of Infection Prevention in Injection Drug Use” provider educational tool was developed using a global, rather than pathogen-specific, infection prevention framework, highlighting t
Original research | 2022
About prescribers, Harm reduction, Clinical guidance, Safer supply, Injecting drugs
The goal of the Best Practice Recommendations is to improve the effectiveness of programs that deliver harm reduction supplies to people who use drugs and are at risk for human immunodeficiency virus
Guide or handbook | 2021
Clinical guidance, Harm reduction, Policy/Regulatory, Wrap-around services, About prescribers, Illegal drugs, Injecting drugs
Commentary | 2022
Overdose, Clinical guidance, Harm reduction, Policy/Regulatory, Hesitancy of prescribers , About prescribers, Illegal drugs, SCS/OPS
